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Abstract 
Background: A relatively high incidence of p values immediately below 0.05 (such as 0.047 or 0.04) compared to p 
values immediately above 0.05 (such as 0.051 or 0.06) has been noticed anecdotally in published medical abstracts. 
If p values immediately below 0.05 are over-represented, such a distribution may reflect the true underlying distribu-
tion of p values or may be due to error (a false distribution). If due to error, a consistent over-representation of p values 
immediately below 0.05 would be a systematic error due either to publication bias or (overt or inadvertent) bias 
within studies.
Methods: We searched the Medline 2012 database to identify abstracts containing a p value. Two thousand abstracts 
out of 80,649 abstracts were randomly selected. Two independent researchers extracted all p values. The p values 
were plotted and compared to a predicted curve. Chi square test was used to test assumptions and significance was 
set at 0.05.
Results: 2798 p value ranges and 3236 exact p values were reported. 4973 of these (82 %) were significant (<0.05). 
There was an over-representation of p values immediately below 0.05 (between 0.01 and 0.049) compared to those 
immediately above 0.05 (between 0.05 and 0.1) (p = 0.001).
Conclusion: The distribution of p values in reported medical abstracts provides evidence for systematic error in the 
reporting of p values. This may be due to publication bias, methodological errors (underpowering, selective reporting 
and selective analyses) or fraud.
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Background
The relatively high incidence of p values immediately 
below 0.05 (such as 0.047 or 0.04) compared to p values 
immediately above 0.05 (such as 0.051 or 0.06) has been 
noted by the authors, and has been previously reported 
in samples of studies reporting effect sizes (Gøtzsche) 
and in psychology studies [1–4]. If p values immediately 
below 0.05 are consistently overrepresented, such a dis-
tribution may reflect either the true underlying distribu-
tion of p values or may be due to systematic error (bias) 
[1, 2]. This bias could be due to publication bias or (overt 
or inadvertent) bias within studies, as described below.
There is some evidence that, due to flexibility in the 
analysis and reporting of research data, the probability 
of finding a p value less than 0.05 can be increased by 
making use of “researcher degrees of freedom” [3]. Such 
degrees of freedom include (but are not limited to) vari-
ability in application of the inclusion and exclusion crite-
ria, in the choice of independent and dependent variables 
in any analysis, and in the choice of analytical methods. 
Selective reporting of the research processes and find-
ings makes such flexibility difficult to detect. The process 
of exploiting flexibilities in the analysis of research data 
has been labeled p-hacking [3, 5, 6]. This may represent 
a form of confirmation bias if researchers make use of 
the flexibility available to them to confirm their a priori 
beliefs.
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It is also possible that differences in reported p values 
may represent publication bias, whereby studies with p 
values above 0.05 are less likely to be published (or sub-
mitted for consideration of publication) compared to 
studies with p values less than 0.05 [7–9]. The contribu-
tion to the over-representation of significant p values in 
the psychology literature, due to publication bias and 
the high proportion of underpowered studies, has been 
calculated previously [10]. If the reporting of p values in 
medical publications is biased in favor of values below 
0.05, this would have consequences for clinical decision 
making, either from direct interpretation of the literature 
or via systematic reviews and guidelines [11].
We aim to estimate the distribution of all p values 
reported in medical scientific abstracts by an unbiased 
pictorial representation of the distribution.
Methods
Search strategy and selection criteria
With the goal of testing a large representative sample of 
the medical literature we used a random sample of all 
abstracts published in Medline in 2012 containing a p 
value. We chose 2012 as it was the most recent full year 
available at the time of the study. We used the following 
search string on 29 October 2013: “2012”.yr. and “p”.ab, 
limited to Abstracts and Humans. The search returned 
80,648 abstracts and these were numbered consecutively. 
We generated 2000 random numbers between 0 and 
80,649 with the random integer generator at http://www.
random.org and selected the corresponding 2000 articles 
for inclusion in the study.
Data extraction
We recorded the unique identifier, abstract text, and 
study type. Two investigators (BG and AA) indepen-
dently extracted all p values from 500 abstracts, showing 
an inter-observer level of agreement of 94.2  %. For the 
remaining 1500 abstracts, data were abstracted by one 
(of two) investigators (750 each), and then checked by the 
other investigator. Inconsistencies between investigators 
were discussed with a third investigator (IAH).
Statistical analysis
Many abstracts did not report a p value, but reported a 
range, usually “p < 0.05” or “p < 0.001”. Ranges of p val-
ues were excluded from the primary analysis. A separate 
study to withdraw these exact p values from their origi-
nal full paper is currently being undertaken. All p val-
ues reported in the abstracts were counted within each 
interval with division of 0.01 and then plotted graphi-
cally. The underlying (expected) distribution of p values 
was estimated by an exponential curve. Chi square test 
was applied to compare the expected distribution versus 
the observed distribution. A significant p value (p < 0.05) 
derived from this Chi square test indicates an improb-
able observed distribution of the p values collected from 
abstracts. A separate analysis was performed for the 
study type randomised controlled trial (RCT) and also 
plotted graphically. The expected distribution in RCTs 
would be uniform if the null hypothesis is correct [12].
Results
Two hundred and twenty-six abstracts out of the selected 
2000, abstracts did not have a p value in their abstract 
and were excluded. Fourteen abstracts did not involve 
humans but were labeled as such by Medline. These were 
included, as they satisfied our a priori criteria of being 
labeled as human research in Medline and because this 
will allow more reliable replication of the study. The 
random selection and inclusion process is shown in 
Fig. 1. The 1774 included abstracts reported 2798 ranges 
(including 1069 p  <  0.001 and 723 p  <  0.05) and 3236 
exact p values. The distribution of the 3236 exact p values 
is shown in Fig. 2. The inset in Fig. 2 is a magnification 
of the distribution of p values between 0.01 and 0.1. A 
relative over-representation of p values between 0.04 and 
0.05 can be seen.
The probability of any p value in our study being less 
than 0.05 (including those given as ranges) was 82  % 
(4973/6034). There were 186 abstracts from RCTs that 
reported 350 true p values. The distribution of the exact 
Fig. 1 Flowchart of included abstracts
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350 p values is shown in Fig.  3. The inset in Fig.  3 is a 
magnification of the distribution of p values between 0.01 
and 0.1.
Discussion
We demonstrated a biased distribution of p values 
in abstracts listed in Medline 2012, with an apparent 
increase in p values lying immediately below 0.05 relative 
to the frequency immediately above 0.05. This finding is 
likely to be evidence of p-hacking (biased analysis and 
reporting) or publication bias. We expected a more uni-
form distribution of p values for randomized trials, based 
on the assumption that these trials are done where equi-
poise exists, indicating that there is no expected differ-
ence between the two groups. However, the distribution 
of p values in this group was similar to the overall group.
Although the graphic presentation of the p value dis-
tribution in this study shows a clear picture, the weak-
ness of this study is the lack of statistical analysis. There is 
no theoretical or calculated true distribution that can be 
used to test against. The decision to use all p values may 
have introduced some bias due to the inclusion of simi-
lar (related) p values from single studies. We also plotted 
the distribution of the first recorded p values, but found 
this to be similar to the distribution of all reported p val-
ues, and as the latter contained more data, we chose to 
report all p values. The p values used in this study were 
only the p values reported in the abstracts. This was 
chosen because many readers only read the abstract, the 
abstract is the only part of the article available in Med-
line, and because the most important p values are likely 
to be reported in the abstract [13, 14]. We excluded p 
value ranges, but this probably led to an underestimation 
of the bias around 0.05, as the reported range was com-
monly given as “p < 0.05” and including these was likely 
to have added to the number of p values immediately 
below 0.05. During data collecting we observed some 
errors in the Medline database. P values greater than one 
were reported and some papers labeled as human were in 
fact non-human. These errors were infrequent and were 
unlikely to have influenced the results. It is possible that, 
given that papers often contain many p values, significant 
p values in the manuscript are more likely to be reported 
in the abstract than values above 0.05. However, we con-
sider this to be another form of selective reporting bias, 
as only the most important outcomes (such as any pri-
mary, patient-important outcomes) should be reported in 
the abstract, regardless of significance.
Gøtzsche commented on the distribution of p values 
between 0.04 and 0.06, noting a higher than expected 
number of values below 0.05 [2]. His study used first-
reported p values in abstracts and noted a higher propor-
tion of significant p values in non-randomised studies 
compared to randomised trials. Gøtzsche noted that the 
high proportion of significant findings in randomised tri-
als is unexpected, given the need for equipoise (presumed 
Fig. 2 All p values between 0 and 1 are plotted in the bottom graph. The inset shows p values between 0.01 and 0.1 in 0.01 divisions
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equivalence of treatment options) in clinical randomised 
trials, which, if present, would lead to an unskewed (flat) 
distribution of p values. He also noted that many of the 
significant p values were incorrectly reported or ana-
lysed. The findings of Gøtzsche are consistent with the 
presence of bias in analysis and reporting and consistent 
with findings of our study. Masicampo et  al., in a study 
of p value distribution in the abstracts of three major 
psychology journals, showed that there were more p 
values immediately below 0.05 than expected, based on 
the p value distribution in other ranges [1]. The distribu-
tion they found matches the distribution in this study. 
Jager and Leek looked at five major medical journals and 
their reported p values over a decade, however they only 
reported the distribution of p values less than 0.05 [15]. 
The distribution reported was similar to our distribution, 
although their study did not provide any information on 
the relative frequency immediately below and above 0.05. 
Simonsohn et  al. suggested in 2013 to use a “p-curve”, 
a graphic p value distribution as a tool to evaluate if 
the literature on a certain topic has been influenced by 
publication bias or p-hacking. They declare that a right 
skewed p-curve is evidence of biased analysis or selective 
reporting [4]. Ioannidis also concluded that significant p 
values were over-represented in a review of meta-anal-
yses of neuroleptic agents for schizophrenia [16]. Apart 
from publications bias and bias in analysis and outcomes 
reporting, Ioannidis added data fabrication as another 
possible cause of an over-representation of significant p 
values.
Distinguishing between publication bias and meth-
odological biases (bias in analysis, selective reporting 
and data fabrication) is difficult. Funnel plot asymmetry, 
often interpreted as evidence of publication bias, can also 
be explained by these other forms of bias, as p values are 
artificially lowered and effect estimates exaggerated [17]. 
However, we consider bias immediately adjacent to 0.05 
(as shown in our study) more likely to be due to methodo-
logical biases (working to push the p value below the level 
of significance), than due to publication bias (which applies 
to all p values below 0.05, not necessarily those immedi-
ately below 0.05). Methodological biases (rather than pub-
lication bias) leading to an over-representation of lower 
p values is also consistent with findings of effect estimate 
exaggeration in research [18–20] and with problems relat-
ing to the replication of significant findings in the medical 
Fig. 3 All p values from RCT type study between 0 and 1 are plotted in the bottom graph. The inset shows p values between 0.01 and 0.1 in 0.01 
divisions
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literature [21–23]. Our study implies that the reporting 
of p values in human research is biased. Further research 
should explore predictors of bias in the distribution of p 
values, such as study type, methodology, study size, and 
journal type. In a later study, we aim to report on the dis-
tribution of p values described as ranges, such as “p < 0.05”, 
and to report on possible predictors of significance.
There is some evidence that the quality of reporting 
abstracts has improved over time due to initiatives such 
as CONSORT [24–26]. However, the reporting require-
ments only apply to some studies (such as randomized 
trials) and do not exclude the possibility of methodologi-
cal biases and selective reporting. Unfortunately there are 
many more reasons why science has been incapable to 
self-correct [27].
Reports of statistical significance in medical research 
influence clinical decision making. Bias in such report-
ing should be considered when interpreting information 
from abstracts. Prevention of bias in reported p values 
would require open and complete reporting of research 
protocols and methods (to avoid analysis and reporting 
bias), adjusted analyses due to multiple testing (allowing 
for the increased probability of finding significance), and 
publication of all research (to avoid publication bias) [28].
Conclusion
A biased distribution of p values in abstracts listed in 
Medline 2012 has been demonstrated, with an apparent 
increase in p values lying immediately below 0.05 relative 
to the frequency immediately above 0.05. This finding is 
likely to be evidence of p-hacking (biased analysis and 
reporting) or publication bias.
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